Fingerprint
Dive into the research topics of 'Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: A multicentre, open-label, phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: A multicentre, open-label, phase 2 trial
Gary K. Schwartz, William D. Tap, Li Xuan Qin, Michael B. Livingston, Samir D. Undevia, Bartosz Chmielowski, Mark Agulnik, Scott M. Schuetze, Damon R. Reed, Scott H. Okuno, Joseph A. Ludwig, Vicki Keedy, Petra Rietschel, Andrew S. Kraft, Douglas Adkins, Brian A. Van Tine, Bruce Brockstein, Vincent Yim, Christiana Bitas, Abdul Abdullah
- Section of Medical Oncology
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
Research output: Contribution to journal › Article › peer-review
176
Scopus
citations